Breast Cancer Center of Excellence

Abstract

The Readiness and Lethality of the Total Force is based in large part on personnel health. Nearly 20% of the active duty force is now female, and breast cancer is the number one cancer in active duty women, far surpassing all other causes of cancer in this population. The Breast Cancer CoE utilizes a multidisciplinary approach for researching breast diseases and breast cancer focused on the military at-risk active duty population in order to enhance Readiness of The Total Force. This multidisciplinary model integrates prevention, screening, early diagnosis, treatment and continuing care, but the project is further unique in the incorporation of advances in risk reduction, biomedical informatics, tissue banking and translational research. The project is based on a Discovery Science paradigm, leveraging high-throughput molecular biology technology and our unique clinically and pathologically well-characterized tissue repository with advances in biomedical informatics leading to hypothesis-generating discoveries that are then tested in hypothesis-driven experiments.

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2022
Source ID
0ef4838f1584ce924b4ef25662585e0a

Tags

Readers

  • Defense Technology Research and Development.
  • Military Mobilization and Reserve Forces Studies.
  • Oncology and Biomarker-Based Cancer Detection.

Technology Areas

  • Biotechnology

Related Documents